BIOMAT Database Logo BIOMAT Database Logo

Multinucleated cells in the lymph nodes of HTLV-III seropositive intravenous drug abusers with generalized lymphadenopathy. 1986

A Carbone, and R Manconi, and R Volpe, and A Polette, and E Vaccher, and U Tirelli

UI MeSH Term Description Entries
D006965 Hyperplasia An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. Hyperplasias
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008206 Lymphatic Diseases Diseases of LYMPH; LYMPH NODES; or LYMPHATIC VESSELS. Lymphatism,Status Lymphaticus,Disease, Lymphatic,Diseases, Lymphatic,Lymphatic Disease
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D019966 Substance-Related Disorders Disorders related to substance use or abuse. Chemical Dependence,Drug Abuse,Drug Addiction,Drug Dependence,Drug Habituation,Drug Use Disorder,Drug Use Disorders,Organic Mental Disorders, Substance-Induced,Substance Abuse,Substance Dependence,Substance Related Disorder,Substance Use,Substance Use Disorder,Substance Use Disorders,Prescription Drug Abuse,Substance Addiction,Abuse, Drug,Abuse, Prescription Drug,Abuse, Substance,Addiction, Drug,Addiction, Substance,Chemical Dependences,Dependence, Chemical,Dependence, Drug,Dependence, Substance,Dependences, Chemical,Disorder, Drug Use,Disorder, Substance Related,Disorder, Substance Use,Disorders, Substance Related,Drug Abuse, Prescription,Habituation, Drug,Organic Mental Disorders, Substance Induced,Related Disorder, Substance,Related Disorders, Substance,Substance Abuses,Substance Uses,Use, Substance

Related Publications

A Carbone, and R Manconi, and R Volpe, and A Polette, and E Vaccher, and U Tirelli
Lymph nodes in HIV-positive drug abusers with persistent generalized lymphadenopathy: histology, immunohistochemistry, and pathogenetic correlations.
January 1990, Progress in AIDS pathology,
A Carbone, and R Manconi, and R Volpe, and A Polette, and E Vaccher, and U Tirelli
HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS.
April 1986, The American journal of pathology,
A Carbone, and R Manconi, and R Volpe, and A Polette, and E Vaccher, and U Tirelli
Persistent generalized lymphadenopathy: clinical characteristics of a lymphadenopathy syndrome in intravenous drug abusers.
January 1986, AIDS research,
A Carbone, and R Manconi, and R Volpe, and A Polette, and E Vaccher, and U Tirelli
HTLV-III antibody in Swiss and English intravenous drug abusers.
August 1985, Lancet (London, England),
A Carbone, and R Manconi, and R Volpe, and A Polette, and E Vaccher, and U Tirelli
Natural killer cells in intravenous drug abusers with lymphadenopathy syndrome.
October 1985, Clinical and experimental immunology,
A Carbone, and R Manconi, and R Volpe, and A Polette, and E Vaccher, and U Tirelli
In situ demonstration of Epstein-Barr virus in intravenous drug abusers with generalized lymphadenopathy.
September 1992, Postgraduate medical journal,
A Carbone, and R Manconi, and R Volpe, and A Polette, and E Vaccher, and U Tirelli
HTLV-III antibody in intravenous drug abusers of metropolitan Barcelona, Spain.
April 1986, Archives of internal medicine,
A Carbone, and R Manconi, and R Volpe, and A Polette, and E Vaccher, and U Tirelli
HTLV-III expression in infected lymph nodes and relevance to pathogenesis of lymphadenopathy.
December 1986, The American journal of pathology,
A Carbone, and R Manconi, and R Volpe, and A Polette, and E Vaccher, and U Tirelli
HTLV-III viremia in homosexual men with generalized lymphadenopathy.
June 1985, The New England journal of medicine,
A Carbone, and R Manconi, and R Volpe, and A Polette, and E Vaccher, and U Tirelli
HTLV among Israeli intravenous drug abusers.
October 1992, International journal of epidemiology,
Copied contents to your clipboard!